These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 21696910)

  • 1. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
    Karikoski NP; Horn I; McGowan TW; McGowan CM
    Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laminitis and the equine metabolic syndrome.
    Johnson PJ; Wiedmeyer CE; LaCarrubba A; Ganjam VK; Messer NT
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):239-55. PubMed ID: 20699172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamellar pathology in horses with pituitary pars intermedia dysfunction.
    Karikoski NP; Patterson-Kane JC; Singer ER; McFarlane D; McGowan CM
    Equine Vet J; 2016 Jul; 48(4):472-8. PubMed ID: 25869529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine laminitis: what is all the hype about hyperinsulinaemic laminitis?
    Wylie CE
    Vet J; 2013 May; 196(2):139-40. PubMed ID: 23168265
    [No Abstract]   [Full Text] [Related]  

  • 5. Field treatment and management of endocrinopathic laminitis in horses and ponies.
    Walsh DM
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):379-90. PubMed ID: 20699182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemic laminitis.
    de Laat MA; McGowan CM; Sillence MN; Pollitt CC
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):257-64. PubMed ID: 20699173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinopathic laminitis.
    McGowan CM
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):233-7. PubMed ID: 20699171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacologic basis for the treatment of endocrinopathic laminitis.
    Durham A
    Vet Clin North Am Equine Pract; 2010 Aug; 26(2):303-14. PubMed ID: 20699177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between hyperinsulinaemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis.
    Tadros EM; Fowlie JG; Refsal KR; Marteniuk J; Schott HC
    Equine Vet J; 2019 Jan; 51(1):52-56. PubMed ID: 29761574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.
    Karikoski NP; McGowan CM; Singer ER; Asplin KE; Tulamo RM; Patterson-Kane JC
    Vet Pathol; 2015 Sep; 52(5):945-56. PubMed ID: 25232034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.
    de Laat MA; McGowan CM; Sillence MN; Pollitt CC
    Equine Vet J; 2010 Mar; 42(2):129-35. PubMed ID: 20156248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies.
    Asplin KE; Sillence MN; Pollitt CC; McGowan CM
    Vet J; 2007 Nov; 174(3):530-5. PubMed ID: 17719811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.
    de Laat MA; Reiche DB; Sillence MN; McGree JM
    J Vet Intern Med; 2019 May; 33(3):1473-1482. PubMed ID: 30972832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
    Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
    Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrinopathic Laminitis.
    Grenager NS
    Vet Clin North Am Equine Pract; 2021 Dec; 37(3):619-638. PubMed ID: 34674908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fructosamine concentrations in horses with pituitary pars intermedia dysfunction with and without laminitis.
    Knowles EJ; Menzies-Gow NJ; Mair TS
    Equine Vet J; 2014 Mar; 46(2):249-51. PubMed ID: 23663105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses.
    de Laat MA; Sillence MN; McGowan CM; Pollitt CC
    Vet J; 2012 Mar; 191(3):317-22. PubMed ID: 21873088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of current laminitis research.
    Eades SC
    Vet Clin North Am Equine Pract; 2010 Apr; 26(1):51-63. PubMed ID: 20381735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
    Donaldson MT; Jorgensen AJ; Beech J
    J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.